In May 2017 the newly named World Advanced Therapies and Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.
The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.
Key topics include:
. The next generation of ATMPs
. Regulation, reimbursement and commercialisation for advanced therapies around the globe
. CRISPR and gene editing
. Stem cells as a tool for drug discovery
. What's next for cell and gene therapy, new era of regenerative medicine?
. New paradigms in manufacture: gene therapy and viral vectors
. Clinical development of immunotherapy and cell therapy
. New frontiers in repair and replacement of diseased tissues and organs
. Product, process and manufacturing development of ATMPS
Current premail standard price (expires January 20th): GBP 2250
Current premail NHS and academic price (expires January 20th): GBP 1090
Speakers: William (Bill) Burns, Governor and Trustee, Wellcome Trust, Vice Chairman, Vestergaard; Trustee, Institute of Cancer Research, London; Vice Chairman, Mesoblast, . Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University, . Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation, .Sonia Quaratino, Global Clinical Program Leader, Novartis Institutes For BioMedical Research, .Sven Kili, Vice President and Head, Gene Therapy Development, GSK
Sign in to add slides, notes or videos to this session